ArticleBMC women's health2026
Prevalence of long-term breast cancer survivors. Should primary care have a more relevant role on follow-up?
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionLong-term breast cancer survivors (LTBCS) are cases in which more than five years have elapsed since diagnosis and there is no evidence of disease. In Spain, the follow-up of these women currently takes the form of medical visits attended at Oncology Departments, though scientific societies recommend that this follow-up be conducted by Primary Care. The aims of this study were to quantify: (a) the prevalence of LTBCS patients in Galicia (Spain); and (b) medical visits attended by LTBCS at Oncology Departments, i.e., visits that could be undertaken in Primary Care.
methodsRetrospective case series including all LTBCS in Galicia diagnosed from January 1, 2001 through December 31, 2017, and alive at June 30, 2022. We sourced the data from Galician Health Service Information Systems, and performed a descriptive analysis.
resultsA total of 15,121 LTBCS were identified. Mean and median age at diagnosis was 57 years. Of the women included, 14,063 did not present with a new breast tumor (93.0%), 991 (6.6%) presented with a new tumor, and 67 presented with two or more new tumors (0.4%). Prevalence of LTBCS was 1.0% overall, 1.2% among women aged 30 years and over without new tumors, and 1.4% among women aged 50 years and over. LTBCS generated a total of 78,717 medical visits at Oncology Departments; 94.1% had attended 20 or fewer medical visits five years or more after diagnosis.
conclusionsPrevalence of LTBCS in Galicia is high, as is the number of medical visits attended at Oncology Departments. These findings would justify specific follow-up protocols being drawn up and implemented by Primary Care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.